19-51452612-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014442.3(SIGLEC8):c.1267A>C(p.Lys423Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014442.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIGLEC8 | NM_014442.3 | c.1267A>C | p.Lys423Gln | missense_variant | Exon 7 of 7 | ENST00000321424.7 | NP_055257.2 | |
SIGLEC8 | NM_001363548.1 | c.988A>C | p.Lys330Gln | missense_variant | Exon 6 of 6 | NP_001350477.1 | ||
SIGLEC8 | XM_011526734.3 | c.1234A>C | p.Lys412Gln | missense_variant | Exon 7 of 7 | XP_011525036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC8 | ENST00000321424.7 | c.1267A>C | p.Lys423Gln | missense_variant | Exon 7 of 7 | 1 | NM_014442.3 | ENSP00000321077.2 | ||
SIGLEC8 | ENST00000340550.5 | c.988A>C | p.Lys330Gln | missense_variant | Exon 6 of 6 | 1 | ENSP00000339448.4 | |||
SIGLEC8 | ENST00000430817.5 | c.940A>C | p.Lys314Gln | missense_variant | Exon 5 of 6 | 2 | ENSP00000389142.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1267A>C (p.K423Q) alteration is located in exon 7 (coding exon 7) of the SIGLEC8 gene. This alteration results from a A to C substitution at nucleotide position 1267, causing the lysine (K) at amino acid position 423 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at